HemoShear has developed a breakthrough cell-based technology that accelerates discovery and assessment of new drug compounds. The technology is far more predictive of human response than traditional methods used in the laboratory. Experiments conducted by HemoShear provide insight into both intended and unintended effects of drug compounds on the vasculature (blood vessel system).

By recreating in vivo human vasculature cell biology in the laboratory, our unique technology provides important and previously unobtainable information on human responses much earlier in the drug R&D process. HemoShear can save pharmaceutical companies hundreds of millions of dollars in R&D expenditures that prove to be misguided because of unreliable data generated by traditional methods. Experiments and interpretation of data are conducted at HemoShear’s own laboratory operations in Charlottesville, Virginia, USA.

HemoShear’s exclusive customers gain strategic, competitive advantages through:
• Faster discovery of novel drug targets
• Discovery of innovative drug compounds
• Comprehensive understanding of the effects of drugs on the vasculature system
• Reduced risk of expensive failures downstream in development
• Repositioning of compounds for new indications
• Development of proprietary surrogate organ and disease models